|
|
|
|
|
My Recent Searches
|
|
|
|
|
|
|
Praxis Precision Medicines, Inc. (PRAX) |
|
|
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30
|
|
Download |
|
|
|
|
Exchange: |
N/A |
Security
Type: |
N/A |
Shares
Out: |
52,390,000 |
Market
Cap: |
N/A |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$ - $ |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Praxis is a clinical-stage biopharmaceutical company that is engaged in developing therapies for central nervous system disorders characterized by neuronal imbalance. Co.'s lead product candidates include PRAX-114, an extrasynaptic-preferring GABAA receptor positive allosteric modulator that is in Phase IIa clinical trial for the treatment of major depressive disorder and perimenopausal depression; and PRAX-944, a selective small molecule inhibitor of T-type calcium channels, which is in Phase IIa clinical trial for the treatment of essential tremor.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
24,500 |
165,502 |
Total Buy Value |
$0 |
$0 |
$35,962 |
$168,567 |
Total People Bought |
0 |
0 |
2 |
5 |
Total Buy Transactions |
0 |
0 |
2 |
8 |
Total Shares Sold |
0 |
0 |
0 |
8,000 |
Total Sell Value |
$0 |
$0 |
$0 |
$6,998 |
Total People Sold |
0 |
0 |
0 |
1 |
Total Sell Transactions |
0 |
0 |
0 |
1 |
End Date |
2024-02-11 |
2023-11-10 |
2023-05-12 |
2022-05-12 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Souza Marcio |
Chief Executive Officer |
|
2021-08-18 |
4 |
B |
$15.79 |
$150,668 |
D/D |
9,542 |
86,792 |
2.81 |
- |
|
Schwarzman Stephen A |
10% Owner |
|
2021-08-12 |
4 |
S |
$13.92 |
$140,035 |
I/I |
(10,060) |
801,942 |
|
- |
|
Schwarzman Stephen A |
10% Owner |
|
2021-08-11 |
4 |
S |
$15.03 |
$258,847 |
I/I |
(17,222) |
812,002 |
|
- |
|
Schwarzman Stephen A |
10% Owner |
|
2021-08-03 |
4 |
S |
$14.99 |
$334,277 |
I/I |
(22,300) |
829,224 |
|
- |
|
Schwarzman Stephen A |
10% Owner |
|
2021-08-02 |
4 |
S |
$15.78 |
$631,200 |
I/I |
(40,000) |
851,524 |
|
- |
|
Schwarzman Stephen A |
10% Owner |
|
2021-07-30 |
4 |
S |
$15.68 |
$248,591 |
I/I |
(15,854) |
891,524 |
|
- |
|
Young William D |
Director |
|
2021-05-13 |
4 |
A |
$0.00 |
$0 |
D/D |
28,473 |
28,473 |
|
- |
|
Norden Gregory |
Director |
|
2021-05-12 |
4 |
A |
$0.00 |
$0 |
D/D |
2,826 |
2,826 |
|
- |
|
Clarus Ventures Iii Gp, L.p. |
10% Owner |
|
2021-05-12 |
4 |
D |
$0.00 |
$0 |
I/I |
(2,700,000) |
4,894,109 |
|
- |
|
Souza Marcio |
Chief Executive Officer |
|
2021-02-12 |
4 |
A |
$0.00 |
$0 |
D/D |
52,800 |
77,250 |
|
- |
|
Mastrocola Lauren |
Principal Accounting Officer |
|
2021-02-12 |
4 |
A |
$0.00 |
$0 |
D/D |
8,200 |
20,418 |
|
- |
|
Sweeny Nicole |
Chief Commercial Officer |
|
2021-02-12 |
4 |
A |
$0.00 |
$0 |
D/D |
16,800 |
16,800 |
|
- |
|
Ravina Bernard |
Chief Medical Officer |
|
2021-02-12 |
4 |
A |
$0.00 |
$0 |
D/D |
24,512 |
80,533 |
|
- |
|
Nemiroff Alex |
General Counsel and Secretary |
|
2021-02-12 |
4 |
A |
$0.00 |
$0 |
D/D |
12,400 |
12,400 |
|
- |
|
Ravina Bernard |
Chief Medical Officer |
|
2021-01-04 |
4 |
OE |
$2.27 |
$102,150 |
D/D |
45,000 |
56,021 |
|
- |
|
Souza Marcio |
Chief Executive Officer |
|
2020-11-10 |
4 |
B |
$26.08 |
$100,304 |
D/D |
3,846 |
24,450 |
2.81 |
- |
|
Mastrocola Lauren |
Principal Accounting Officer |
|
2020-11-02 |
4 |
OE |
$3.30 |
$40,319 |
D/D |
12,218 |
12,218 |
|
- |
|
Vitorovic Stefan |
Director |
|
2020-10-20 |
4/A |
B |
$19.00 |
$4,750,000 |
I/I |
250,000 |
2,939,329 |
2.1 |
- |
|
Schwarzman Stephen A |
10% Owner |
|
2020-10-20 |
4 |
A |
$0.00 |
$0 |
I/I |
7,800,553 |
7,594,109 |
|
- |
|
Blackstone Alternative Solutions L.l.c. |
10% Owner |
|
2020-10-20 |
4 |
A |
$0.00 |
$0 |
I/I |
7,800,553 |
7,594,109 |
|
- |
|
Novo A/s |
10% Owner |
|
2020-10-20 |
4 |
A |
$0.00 |
$0 |
D/D |
2,442,080 |
2,442,080 |
|
- |
|
Souza Marcio |
Chief Executive Officer |
|
2020-10-20 |
4 |
A |
$0.00 |
$0 |
D/D |
20,604 |
20,604 |
|
- |
|
Vitorovic Stefan |
Director |
|
2020-10-20 |
4 |
A |
$0.00 |
$0 |
I/I |
2,689,329 |
2,689,329 |
|
- |
|
Reddy Kiran |
Director |
|
2020-10-15 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
467,289 |
|
- |
|
Schwarzman Stephen A |
10% Owner |
|
2020-10-15 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
700,934 |
|
- |
|
77 Records found
|
|
Page 3 of 4 |
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Acquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|